In vitro immunomodulatory activity of oxymatrine on toll-like receptor 9 signal pathway in chronic hepatitis B

American Journal of Chinese Medicine

Volumn 42, Issue 6, 2014, Pages 1399-1410

  Yao, Ning ^a   Wang, Xin ^b  

^a GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hepatitis B Virus; Immunomodulatory Activity; Oxymatrine; Toll Like Receptor

Indexed keywords

ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; OXYMATRINE; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; ALKALOIDS; CYTOKINES; IMMUNOLOGIC FACTORS; LIGANDS; PLANT EXTRACTS; QUINOLIZINES; TOLL-LIKE RECEPTOR 9;

ARTICLE; CELL STIMULATION; CELLULAR SECRETION; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELLS, CULTURED; DRUG EFFECTS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOLOGY; LYMPHOCYTES; SECRETION; SOPHORA;

ALKALOIDS; CELLS, CULTURED; CYTOKINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNOLOGIC FACTORS; LIGANDS; LYMPHOCYTES; PLANT EXTRACTS; QUINOLIZINES; SIGNAL TRANSDUCTION; SOPHORA; TOLL-LIKE RECEPTOR 9;

EID: 84929325119     PISSN: 0192415X     EISSN: 17936853     Source Type: Journal    
DOI: 10.1142/S0192415X14500888     Document Type: Article

References (31)

1. Aderem, A. and R.J. Ulevitch. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787, 2000.
2. Cardell, K., B. Akerlind, M. Sallberg and A. Fryden. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J. Infect. Dis. 198: 299-304, 2008.
3. Chen, K., J. Huang, W. Gong, P. Iribarren, N.M. Dunlop and J.M. Wang. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 7: 1271-1285, 2007.
4. Chen, Y.K., D.Y. Wang, Y.L. Hua, Z.H. Guo, J.M. Wang, X.N. Zhao, Y.P. Fan, L.W. Guo, S.J. Yang, F.D. Sai and Y.J. Xing. Astragalus polysaccharide and oxymatrine can synergistically improve the immune efficacy of Newcastle disease vaccine in chicken. Int. J. Biol. Macromol. 46: 425-428, 2010.
5. Czarniecki, C.W. The role of tumor necrosis factor in viral disease. Antiviral Res. 22: 223-258, 1993.
6. Dong, Y., H. Xi, Y. Yu, Q. Wang, K. Jiang and L. Li. Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: A study on the anti-hepatitis B virus mechanism of oxymatrine. J. Gastroent erol. Hepatol. 17: 1299-1306, 2002.
7. European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J. Hepatol. 57: 167-185, 2012.
8. Gao, L.M., Y.X. Han, Y.P. Wang, Y.H. Li, Y.Q. Shan, X. Li, Z.G. Peng, C.W. Bi, T. Zhang, N.N. Du, J.D. Jiang and D.Q. Song. Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70. J. Med. Chem. 54: 869-876, 2011.
9. Honda, K., Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, A. Takaoka, N. Yoshida and T. Taniguchi. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035-1040, 2005.
10. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, A.M. Krieg and G. Hartmann. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to Cp G oligodeoxynucleotides. J. Immunol. 168: 4531-4537, 2002.
11. Kawai, T. and S. Akira. TLR signaling. Cell Death Differ. 13: 816-825, 2006.
12. Kawai, T., S. Sato, K.J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai, M. Matsuda, J. Inoue, S. Uematsu, O. Takeuchi and S. Akira. Interferon-alpha induction through Toll-like receptors involves a direct interaction of I RF7 with MyD88 and TRAF6. Nat. Immunol. 5: 1061-1068, 2004.
13. Krug A. S. Rothenfusser V. Hornung B. Jahrsdorfer S. Blackwell Z.K. Ballas, S. Endres, A.M. Krieg and G. Hartmann. Identificat ion of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31 2154-2163 2001.
14. Kumagai, Y., O. Takeuchi and S. Akira. TLR9 as a key receptor for the recognition of DNA. Adv. Drug Deliv. Rev. 60: 795-804, 2008.
15. Lu, L.G., M.D. Zeng, Y.M. Mao, J.Q. Li, M.B. Wan, C.Z. Li, C.W. Chen, Q.C. Fu, J.Y. Wang, W.M. She, X. Cai, J. Ye, X.Q. Zhou, H. Wang, S.M. Wu, M.F. Tang, J.S. Zhu and W.X. Chen. Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebocontrolled multi-center t rial. World J. Gastroenterol. 9: 2480-2483, 2003.
16. Lu, L.G., M.D. Zeng, Y.M. Mao, M.B. Wan, C.Z. Li, C.W. Chen, Q.C. Fu, J.Y. Wang, W.M. She, X. Cai, J. Ye, X.Q. Zhou, H. Wang, S.M. Wu, M.F. Tang, J.S. Zhu and W.X. Chen. Oxymatrine in the treatment of chronic hepatitis B for one year: A multicenter random double-blind placebo-controlled trial. Zhonghua Gan Zang Bing Za Zhi 12: 597-600, 2004.
17. Pasare, C. and R. Medzhitov. Toll-like receptors: Linking innate and adaptive immunity. Microbes Infect. 6: 1382-1387, 2004.
18. Qiu, L.P. and K.P. Chen. Anti-HBV agents derived from botanical origin. Fitoterapia 84: 140-157, 2013.
19. Ross, J.W., M.D. Ashworth, A.G. Hurst, J.R. Malayer and R.D. Geisert. Analysis and characterization of differential gene expression during rapid trophoblastic elongation in the pig using suppression subtractive hybridization. Reprod. Biol. Endocrinol. 1: 23, 2003.
20. Schroder, K., P.J. Hertzog, T. Ravasi and D.A. Hume. Interferon-gamma: An overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189, 2004.
21. Takeda, K. and S. Akira. T oll-like receptors in innate immunity. Int. Immunol. 17: 1-14, 2005.
22. Verthelyi, D., K.J. Ishii, M. Gursel, F. Takeshita and D.M. Klinman. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166: 2372-2377, 2001.
23. Wagner, H. The immunobiology of the TLR9 subfamily. Trends Immunol. 25: 381-386, 2004.
24. Wai, C.T. and A.S. Lok. Treatment of hepatitis B. J. Gastroenterol. 37: 771-778, 2002.
25. Xu, W.S., K.K. Zhao, X.H. Miao, W. Ni, X. Cai, R.Q. Zhang and J.X. Wang. Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro. World J. Gastroenterol. 16: 2028-2037, 2010.
26. Xu, Y., Y. Hu, B. Shi, X. Zhang, J. Wang, Z. Zhang, F. Shen, Q. Zhang, S. Sun and Z. Yuan. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol. Immunol. 46: 2640-2646, 2009.
27. Yu, X.H., J.S. Zhu, H.F. Yu and L. Zhu. Immunomodulatory effect of oxymatrine on induced CCl4-hepatic fibrosis in rats. Chin. Med. J. (Engl) 117: 1856-1858, 2004.
28. Zeng, F.L., Y.F. Xiang, Z.R. Liang, X. Wang, D.E. Huang, S.N. Zhu, M.M. Li, D.P. Yang, D.M. Wang and Y.F. Wang. Anti-hepatitis B virus effects of dehydrocheilanthifoline from Corydalis saxicola. A m. J. Chin. Med. 41: 119-130, 2013.
29. Zhang, Y.F., S.Z. Wang, Y.Y. Li, Z.Y. Xiao, Z.L. Hu and J.P. Zhang. Sophocarpine and matrine inhibit the production of TNF-α and IL-6 in murine ma crophages and prevent cachexia-related symptoms induced by colon 26 adenocarcinoma in mice. Int. Immunopharmacol. 8: 1767-1772, 2008.
30. Zhou, J., Y. Huang, D. Tian, D. Xu, M. Chen and H. Wu. Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. J. Huazhong Univ. Sci. Technolog. Med. Sci. 29: 313-317, 2009.
31. Zoulim, F. and S. Locarnini. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 137: 1593-1608, e1591-e1592, 2009.